Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

NCT04587713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Intestinal Disorder
Bowel Diseases, Inflammatory

Interventions

DRUG: TD-1473 [Tablet A]
DRUG: TD-1473 [Tablet B]

Sponsor

Theravance Biopharma